文献速递前列腺增生与排尿功能障碍

机器人辅助单纯前列腺切除术与其他治疗方式治疗大体积良性前列腺增生的系统综述与Meta分析:超过6500例病例

Robotic assisted simple prostatectomy versus other treatment modalities for large benign prostatic hyperplasia: a systematic review and meta-analysis of over 6500 cases.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2022-11-19

该系统综述与Meta分析纳入15项研究共6659例患者,比较机器人辅助单纯前列腺切除术(RASP)与开放单纯前列腺切除术(OSP)、腹腔镜单纯前列腺切除术(LSP)及激光前列腺剜除术(EEP)的安全性与有效性。RASP与OSP相比手术时间更长但术后并发症率、住院时间、估计出血量和输血率更低;与激光EEP相比RASP住院时间和导尿时间更长且输血率更高;各组功能结局无差异。

要点

  • RASP与OSP相比功能结局相当且安全性更好,但手术时间更长。
  • RASP与激光EEP相比住院时间和导尿时间更长、输血率更高。
  • RASP与LSP相比住院时间更短但术后SHIM评分更低,其他指标无差异。

核心结论

  • RASP已成为不受前列腺体积限制的治疗大体积前列腺所致膀胱前列腺梗阻(BPO)的方式,可复制OSP的功能结局并提供更好的安全性。
  • 与LSP相比,LSP仍是有效的低成本选择,但需要扎实的腹腔镜技能,因此不太可能大规模推广。
  • 与激光EEP相比,RASP学习曲线更短,但仍存在导尿时间和住院时间更长的缺点。

研究设计与样本

  • 系统检索MEDLINE、EMBASE和Web of Science数据库,纳入比较RASP与OSP或LSP或激光EEP(HoLEP/ThuLEP)的回顾性和前瞻性研究。
  • 遵循PRISMA建议设计检索策略、选择标准和证据报告,采用加权均数差和风险比比较连续变量和二分类变量。
  • 共纳入15项研究6659例患者:13项观察性研究、1项非随机前瞻性研究和1项随机对照试验。
  • 使用Newcastle-Ottawa量表和Cochrane协作组工具评估文献质量和偏倚风险。

主要发现

  • RASP与OSP相比手术时间(OT)显著更长,术后并发症率、住院时间(LOS)、估计出血量(EBL)和输血率(TR)显著更低。
  • LSP与RASP相比住院时间更长、术后SHIM评分更低,手术时间、估计出血量和并发症无差异。
  • RASP与激光EEP相比住院时间和导尿时间更长、输血率更高;ThuLEP与RASP相比手术时间更短。
  • 各组间主观功能结局(IPSS、QoL)和客观功能结局(Qmax、PVR)均无差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Current guidelines recommend simple prostatectomy or endoscopic enucleation of the prostate (EEP) as treatment of choice for bladder prostatic obstruction (BPO) caused by large prostate glands. We aimed to provide a wide-ranging analysis of the currently available evidence, comparing safety and effectiveness of robot-assisted simple prostatectomy (RASP) versus open simple prostatectomy (OSP), laparoscopic simple prostatectomy (LSP), and laser EEP. METHODS: A systematic search was performed across MEDLINE, EMBASE, and Web of Science databases for retrospective and prospective studies comparing RASP to OSP or LSP or laser EEP (HoLEP/ThuLEP). Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) recommendations were followed to design the search strategies, selection criteria, and evidence report. A meta-analysis evaluated perioperative safety and effectiveness outcomes. The weighted mean difference and risk ratio were used to compare continuous and dichotomous variables, respectively. Quality was assessed using the Newcastle-Ottawa scale and the Cochrane Collaboration's tool for RCT article assessing risk of bias. RESULTS: 15 studies, including 6659 patients, were selected for meta-analysis: 13 observational studies, 1 non-randomized prospective study, and 1 randomized controlled trial. RASP was associated with statistically significant longer operative time (OT) and lower postoperative complication rate, length of stay (LOS), estimated blood loss (EBL), and transfusion rate (TR) compared to OSP. LSP showed longer LOS and lower postoperative SHIM score, with no difference in OT, EBL, and complications. Compared to laser EEP, RASP presented longer LOS and catheterization time and higher TR. ThuLEP presented shorter OT than RASP. No difference were found in functional outcomes between groups both subjectively (IPSS, QoL) and objectively (Qmax, PVR). CONCLUSION: RASP has become a size-independent treatment for the management of BPO caused by a large prostate gland. It can duplicate the functional outcomes of OSP while offering a better safety profile. When compared to LSP, the latter still stands as a valid lower-cost option, but it requires solid laparoscopic skill sets and therefore it is unlikely to spread on larger scale. When compared to laser EEP, RASP offers a shorter learning curve, but it still suffers from longer catheterization time and LOS.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Pandolfo SD, Del Giudice F, Chung BI, et al. Robotic assisted simple prostatectomy versus other treatment modalities for large benign prostatic hyperplasia: a systematic review and meta-analysis of over 6500 cases. Prostate Cancer Prostatic Dis. 2022. PMID: 36402815. doi:10.1038/s41391-022-00616-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。